We discuss the consequences of the presence of a highly toxic PHF core in the early stages of tau processing in Alzheimer's disease and discuss how phosphorylated tau may act in a protective manner against the toxicity of the PHF core. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.